CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.

As part of Sanner’s strategic transformation into a Contract Development and Manufacturing Organization (CDMO) for medical ...

Intas Pharmaceuticals in collaboration with its global Accord brand subsidiaries, has acquired UDENYCA (pegfilgrastim-cbqv) ...

Modeyso is the first and only treatment option approved by the FDA for this ultra-rare and aggressive brain tumor that affects an estimated 2,000 people in the U.S. each year, many of whom are ...

Minghui Pharmaceutical ( Minghui ), a late-stage clinical biopharmaceutical company, announced the closing of a $131 million ...

Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Buildout includes Gerteis Macro-Pactor install to meet growing demand for complex oral solid dose development and manufacturing.

Stamoulis joins Mallinckrodt from Incyte, a leading biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. In addition ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova.

Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...